Low-density ZIF-8 coating optimizes the immune microenvironment of 3D-printed PCL scaffolds and promotes cranial defect repair
Qianyu Xie , Xusihong Cai , Guangquan Zhao , Hao Tang , Yuanhao Lv , Jiaxiang Song , Shuai Huang , Weikang Xu , Qingde Wa
International Journal of Bioprinting ›› 2026, Vol. 12 ›› Issue (3) : 026170150
The hydrophobicity of 3D-printed polycaprolactone (PCL) scaffolds leads to insufficient cell adhesion, limiting their application in bone repair. This study constructed zeolitic imidazolate framework-8 (ZIF-8) modified PCL scaffolds with different coating densities and systematically evaluated their physicochemical properties and osteogenic effects. The results showed that low-density ZIF-8-coated PCL scaffolds exhibited better biocompatibility and osteogenic differentiation promotion capacity, while maintaining structural stability and mechanical properties. Mechanistically, the low-density coating can induce macrophages toward M2 polarization, thereby forming a more favorable osteogenic immune microenvironment. Simultaneously, in a rat skull defect model, this scaffold significantly promoted new bone regeneration and defect repair. This study indicates that ZIF-8 coating density is a key parameter affecting the immunomodulatory osteogenic efficacy of PCL scaffolds, providing a basis for the design and optimization of metal–organic framework-based coated scaffolds.
3D-printed scaffold / Polycaprolactone / Zeolitic imidazolate framework-8 / Macrophage polarization / Bone regeneration
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
/
| 〈 |
|
〉 |